Catalyst Pharmaceuticals SG&A Expense (TTM) Insights

Catalyst Pharmaceuticals Inc (CPRX)

15.80 +0.03 (+0.19%) USD | NASDAQ | Jul 02, 16:00

15.82 +0.02 (+0.09%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	150.93M
December 31, 2023	133.71M
September 30, 2023	105.76M
June 30, 2023	85.85M
March 31, 2023	70.37M
December 31, 2022	57.08M
September 30, 2022	56.22M
June 30, 2022	54.73M
March 31, 2022	53.34M
December 31, 2021	49.63M
September 30, 2021	49.75M
June 30, 2021	47.59M
March 31, 2021	46.89M
December 31, 2020	44.23M
September 30, 2020	42.29M
June 30, 2020	40.37M
March 31, 2020	38.53M
December 31, 2019	36.88M
September 30, 2019	32.40M
June 30, 2019	27.97M
March 31, 2019	21.62M
December 31, 2018	15.88M
September 30, 2018	11.06M
June 30, 2018	9.014M
March 31, 2018	8.113M

Date	Value
December 31, 2017	7.304M
September 30, 2017	6.691M
June 30, 2017	6.509M
March 31, 2017	7.085M
December 31, 2016	7.910M
September 30, 2016	8.777M
June 30, 2016	9.332M
March 31, 2016	9.346M
December 31, 2015	8.597M
September 30, 2015	7.837M
June 30, 2015	7.085M
March 31, 2015	5.656M
December 31, 2014	4.474M
September 30, 2014	3.513M
June 30, 2014	2.731M
March 31, 2014	2.361M
December 31, 2013	2.215M
September 30, 2013	2.337M
June 30, 2013	2.524M
March 31, 2013	2.537M
December 31, 2012	2.562M
September 30, 2012	2.875M
June 30, 2012	2.763M
March 31, 2012	2.720M
December 31, 2011	2.698M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

32.40M

Minimum

Sep 2019

150.93M

Maximum

Mar 2024

62.98M

Average

49.75M

Median

Sep 2021

SG&A Expense (TTM) Benchmarks